Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma

Published:2001-04 Issue:4 Volume:21 Page:257-263
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Motzer Robert J.¹,Rakhit Ashok²,Thompson John A.³,Nemunaitis John⁴,Murphy Barbara A.⁵,Ellerhorst Julie⁶,Schwartz Lawrence H.⁷,Berg William J.¹,Bukowski Ronald M.⁸

Affiliation:

1. Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

2. Hoffmann-La Roche, Inc., Nutley, NJ

3. University of Washington, Seattle, WA

4. US Oncology, Dallas, TX

5. Vanderbilt University, Nashville, TN

6. University of Texas M.D. Anderson Cancer Center, Houston, TX

7. Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY

8. The Cleveland Clinic Foundation, Cleveland, OH

Publisher

Mary Ann Liebert Inc

Subject